Sulindac

This classification denotes a cyclooxygenase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 184SNS8VUH. European Medicines Agency schedules Sulindac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10744MIG. Sulindac generally arises in the molecular formula C20H17FO3S. The term SULINDAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, no. 10 1975, list 15.) SULINDAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulindac under HS 29309085 and SITC 51549. As of Q4 2014, SULINDAC remains the US FDA Preferred Term for this commodity. Sulindac bears US NLM identifiers UMLS ID C0038792 and NCI Concept Code C850. SMILES: S(=O)(C1CCC(/C=C2\C(=C(C3C2CCC(F)C3)CC(=O)O)C)CC1)C.